Global Cheilectomy Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Method;

Open, Arthroscopic, and Percutaneous.

By Anesthesia;

General, Local, and Regional Anesthesia.

By Medication;

Prescription Pain Relievers - Corticosteroids, Opioids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), OTC Drugs, and Others.

By End User;

Academic Institutes, Hospitals, and Pharmacies.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn118410952 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Cheilectomy Market (USD Million), 2021 - 2031

In the year 2024, the Global Cheilectomy Market was valued at USD 250.37 million. The size of this market is expected to increase to USD 352.30 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.0%.

Cheilectomy is a surgical intervention designed to address a common issue characterized by the presence of a bony lump on the top of the metatarsophalangeal joint, primarily affecting the big toe. This condition, known as hallux rigidus, is a form of arthritis specific to the big toe joint. Research published in the World Journal of Orthopedics in identifies hallux rigidus as a degenerative ailment affecting the first metatarsophalangeal (MTP) joint, with an estimated prevalence of 1 in 40 individuals aged 50 or older. Notably, females exhibit a higher susceptibility to this condition compared to males, with a ratio of 2:1. Consequently, the rising prevalence of hallux rigidus, coupled with the increasing female population, serves as primary drivers for market growth in the forecast period.

The market for cheilectomy procedures is anticipated to witness further expansion due to escalating demand for minimally invasive surgical techniques and a concurrent rise in healthcare spending. The World Health Organization projects a significant increase in the geriatric population, expected to surge from 524 million in 2010 to approximately 1.5 billion. This demographic shift underscores the need for effective treatment options to manage conditions like hallux rigidus. Despite these growth drivers, challenges such as the high procedural costs associated with cheilectomy procedures, potential complications such as deep vein thrombosis, the necessity for repeat surgeries, joint stiffness, and disparities in healthcare expenditure across middle and low-income countries may impede market growth during the projected period. For instance, data from the Fairfield Independent Hospital suggests that the procedural cost for cheilectomy was approximately posing financial barriers to access for some patients.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Method
    2. Market Snapshot, By Anesthesia
    3. Market Snapshot, By Medication
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Cheilectomy Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Prevalence of Hallux Rigidus and Foot Disorders

        2. Growing Demand for Minimally Invasive Procedures

        3. Rising Healthcare Expenditure and Technological Advancements

      2. Restraints
        1. High Procedural Costs

        2. Complications and Risks Associated with Surgery

        3. Limited Access to Healthcare Services in Low-Income Countries

      3. Opportunities
        1. Technological Advancements in Surgical Techniques

        2. Growing Demand for Minimally Invasive Procedures

        3. Increasing Focus on Geriatric Population Healthcare

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Cheilectomy Market, By Method, 2021 - 2031 (USD Million)
      1. Open
      2. Arthroscopic
      3. Percutaneous
    2. Global Cheilectomy Market, By Anesthesia, 2021 - 2031 (USD Million)
      1. General
      2. Local
      3. Regional Anesthesia
    3. Global Cheilectomy Market, By Medication, 2021 - 2031 (USD Million)
      1. Prescription Pain Relievers
        1. Corticosteroids
        2. Opioids
        3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
      2. OTC Drugs
      3. Others
    4. Global Cheilectomy Market, By End User, 2021 - 2031 (USD Million)
      1. Academic Institutes
      2. Hospitals
      3. Pharmacies
    5. Global Cheilectomy Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Henry Schein, Inc.

      2. STEROID S.p.A.

      3. Pfizer Inc.

      4. Novartis AG

      5. Merck & Co., Inc.

      6. Sanofi

      7. Janssen Pharmaceuticals, Inc.

      8. PurduePharma

      9. ALLERGAN

      10. Boehringer Ingelheim International GmbH

  7. Analyst Views
  8. Future Outlook of the Market